Abvc Biopharma (ABVC) Operating Margin Growth (1y) (2011 - 2025)
Abvc Biopharma (ABVC) Operating Margin Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.03 Bn | 131.18 Bn | 2.84 Bn | -143.00 |
| 2 | Regeneron Pharmaceuticals | 85.64 Bn | 77.64 Bn | 3.93 Bn | 78.00 |
| 3 | Argenx Se | 64.93 Bn | 59.75 Bn | 1.37 Bn | 1,135.00 |
| 4 | Moderna | 57.93 Bn | 52.80 Bn | 52.00 Mn | 7,666.00 |
| 5 | BeOne Medicines | 41.95 Bn | 36.86 Bn | 1.53 Bn | 1,238.00 |
| 6 | Alnylam Pharmaceuticals | 31.51 Bn | 28.20 Bn | 992.69 Mn | 2,002.00 |
| 7 | BioNTech SE | 28.00 Bn | 9.60 Bn | 668.28 Mn | -3,558.00 |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 29,091.00 |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | -1,651.00 |
| 10 | Abvc Biopharma | 23.19 Mn | 23.19 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.61 Mn |
| Dec 31, 2024 | -1.22 Mn |
| Sep 30, 2024 | 1.35 Mn |
| Jun 30, 2024 | 3.52 Mn |
| Mar 31, 2024 | -23.41 Mn |
| Dec 31, 2023 | -2.31 Mn |
| Sep 30, 2023 | -477,538.00 |
| Jun 30, 2023 | -3.53 Mn |
| Mar 31, 2023 | 2.27 Mn |
| Dec 31, 2022 | -216,996.00 |
| Sep 30, 2022 | -680,046.00 |
| Jun 30, 2022 | 581,984.00 |
| Mar 31, 2022 | -2.38 Mn |
| Dec 31, 2021 | 943,734.00 |
| Sep 30, 2021 | -87,431.00 |
| Jun 30, 2021 | -594,695.00 |
| Mar 31, 2021 | 101,073.00 |
| Dec 31, 2020 | -667,509.00 |
| Sep 30, 2020 | -55,196.00 |
| Jun 30, 2020 | -27,225.00 |